Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Immutep (IMMP)

NASDAQ:IMMP

US Market

IMMP

Immutep

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Immutep (IMMP) Stock News & Sentiment

650 Followers

Immutep Advances to Phase III with Key Approvals and Promising Trial Results

Company Announcements

Immutep Advances to Phase III with Key Approvals and Promising Trial Results

19d ago

Immutep Reports Promising Phase II Sarcoma Trial Results

Company Announcements

Immutep Reports Promising Phase II Sarcoma Trial Results

3M ago

Immutep’s Promising Lung Cancer Trial Results

Company Announcements

Immutep’s Promising Lung Cancer Trial Results

3M ago

Immutep’s Growth and Advancements Boost Market Visibility

Company Announcements

Immutep’s Growth and Advancements Boost Market Visibility

4M ago

Immutep Advances Breast Cancer Immunotherapy Trial

Company Announcements

Immutep Advances Breast Cancer Immunotherapy Trial

5M ago

Immutep’s Efti Shows Promise in Cancer Therapy

Company Announcements

Immutep’s Efti Shows Promise in Cancer Therapy

5M ago

Immutep: Quarterly Rebalance of S&P/ASX Indices

Company Announcements

Immutep: Quarterly Rebalance of S&P/ASX Indices

6M ago

More IMMP News >

IMMP News on the Web

2025-01-31

Immutep Quarterly Activities Report Q2 FY25

Yahoo Finance

Neutral

2024-12-13

Immutep’s Eftilagimod Alpha Shows Promising Results in Head and Neck Cancer Study, Justifying Buy Rating

TipRanks News

Bullish

2024-10-17

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial

Yahoo Finance

Neutral

2024-10-10

Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit

Yahoo Finance

Neutral

2024-10-04

Immutep concludes participant enrolment in Phase II breast cancer trial

Clinical Trials Arena

Neutral

2024-10-03

Immutep Completes Patient Enrolment in Randomised Phase II of AIPAC-003 Trial in Metastatic Breast Cancer

Yahoo Finance

Neutral

2024-09-24

Immutep Receives A$3.6 million R&D Tax Incentive from French Government

Yahoo Finance

Neutral

2024-09-19

Buy Rating Affirmed for Immutep on Promising Efti Outlook Despite Mixed Study Interpretations

TipRanks News

Bullish

News Score - Last 7 Days

Neutral

IMMP

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMMP’s Media Buzz Sentiment?

Currently, no data Available

What is IMMP’s weekly average amount of articles?

Currently, no data Available

What is IMMP’s News Sentiment?

50% of articles about IMMP were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

SHGSingular Health Group Ltd

RCUSArcus Biosciences

HCMHUTCHMED

PENPenumbra

AMNAMN Healthcare Services

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing